Document is current

Documents that mention this clinical trial

Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight ^(Results)
https://doi.org/10.2337/dc19-1769

Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort ^(Results)
https://doi.org/10.2337/dc20-1787

Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study)
https://doi.org/10.1161/circulationaha.123.066604

Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) ^(Results)
https://doi.org/10.2337/dc19-0901

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
https://doi.org/10.1016/s0140-6736(14)60794-7

Shape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with metformin
https://doi.org/10.1136/bmjdrc-2021-002264

Association of Glycemia, Lipids, and Blood Pressure With Cognitive Performance in People With Type 2 Diabetes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
https://doi.org/10.2337/dc20-2858

Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort
https://doi.org/10.1136/bmjdrc-2022-003159